{"nct_id":"NCT01928940","title":"Japan PhI/II of GSK2118436 and GSK1120212 Combination in Subjects With BRAF V600E/K Mutation Positive Advanced Solid Tumors (Phase I Part) or Cutaneous Melanoma (Phase II Part)","status":"COMPLETED","status_verified_date":"2017-07","start_date":"2013-08-15","start_date_type":null,"primary_completion_date":"2014-09-18","primary_completion_date_type":"ACTUAL","completion_date":"2016-07-04","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}